Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2003
11/20/2003US20030216417 Substituted anilino-quinoline compounds and use thereof
11/20/2003US20030216406 Pyrimidine derivatives
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216392 Aryl or heteroaryl substituted ethylcarbonylsulfonamide derivatives used as inhibitors of neutrophils chemotaxis and degranulation induced by interleukin 8
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030216367 In perimenopausal, menopausal, and postmenopausal women through the sequential administration of combinations of conjugated estrogens and trimegestone
11/20/2003US20030216356 Cause the selective destruction of tumour vasculature; are used to inhibit and/or reverse, and/or alleviate symptoms of angiogenesis
11/20/2003US20030216335 Treating endometriosis by contacting the subject with a nucleic acid that modulates the expression of VEGF, VEGFR1, and/or VEGFR2
11/20/2003US20030215921 Vascular endothelial growth factor-2
11/20/2003US20030215879 Comprise enzymatic polypeptide for use in the treatment of inflammation; aniinflammatory agents
11/20/2003US20030215852 Novel pancortin-Pablo protein interactions and methods of use thereof
11/20/2003US20030215831 Renal regulatory elements and methods of use thereof
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215556 Reduced calorie fat compositions
11/20/2003US20030215530 Tea extracts used for prophylaxis of alergies, atopic diseases or skin disorders
11/20/2003US20030215522 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
11/20/2003US20030215496 Solid carrier includes a hydrophililc surfactant and a drug
11/20/2003US20030215472 Such as dimethylmyristamide for use in deodorants/cosmetics/ antiperspirants
11/20/2003US20030215447 Produced by hybridoma cell line DSM ACC 2533
11/20/2003US20030215414 Compositions comprising a combination of a free sphingoid base and a ceramide and uses thereof
11/20/2003US20030215408 Combination antiperspirant and antimicrobial composition
11/20/2003US20030215406 For use in treating undesired pigmentation of the skin
11/20/2003US20030213920 Methods for sterilizing preparations containing albumin
11/20/2003CA2485527A1 Substituted pyrroline kinase inhibitors
11/20/2003CA2485380A1 A pharmaceutical composition for the treatment of seborrhea containing ovalicin
11/20/2003CA2485373A1 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003CA2484770A1 Carbon monoxide as a biomarker and therapeutic agent
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2480488A1 Novel diazabicyclic biaryl derivatives
11/20/2003CA2480378A1 Novel azacyclic ethynyl derivatives
11/20/2003CA2474947A1 Combination of a growth factor and a protease enzyme
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362600A1 Pharmaceutical compositions containing decoy and method of using the same
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003EP1362581A2 Combination antiperspirant and antimicrobial compositions
11/19/2003EP1362106A2 Streptococcus pyogenes polypeptides and corresponding dna fragments
11/19/2003EP1362105A2 Anti-interferon-alpha antibodies
11/19/2003EP1362104A2 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/19/2003EP1362095A2 Post-partum mammalian placenta, its use and placental stem cells therefrom
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362050A1 Pyrimidine derivatives for inhibition of cell-proliferation
11/19/2003EP1362048A1 Triazolo compounds as mmp inhibitors
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362045A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362043A1 Lactone compounds as novel photoinitiators
11/19/2003EP1361880A2 6-substituted pyrido-pyrimidines
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1361863A2 Carotenoid-loaded liposomes
11/19/2003EP1361854A1 Topical solution containing a chromane or chromene derivative
11/19/2003EP1361850A1 Use of (gamma-hydroxy-n-methyl-l-leucine9) cyclosporin a for hair growth
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP1117628B1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/19/2003EP1017667B1 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0956048B1 Stable compositions containing a retinoid and an enzyme based antioxidant system
11/19/2003EP0955996B1 Skin care compositions containing an amide and a retinoid
11/19/2003EP0815144B1 Therapeutic uses of glucan
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0756477B1 Methods for phototherapeutic treatment of proliferative skin diseases
11/19/2003CN1457340A Petrides and derivatives thereof showing cell attachment, spreading and detachment activity
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1456362A Artificial skin, preparing method and application thereof
11/19/2003CN1456347A Medicine against psoriasis
11/19/2003CN1456340A External applied pedicure ointment
11/19/2003CN1456339A Cauma therapentic liquid
11/19/2003CN1456331A Swelling healed pill
11/19/2003CN1456330A Scar eliminating medicine
11/19/2003CN1456327A Chinese medicinal herb for treating psoriasis
11/19/2003CN1456325A Transcription against leukoplakia and production of its products
11/19/2003CN1456316A Leucoderma liquid
11/19/2003CN1456310A Sensitive plant oil against burns, its preparation and use
11/19/2003CN1456287A Preparation of Zengkangning tablets against leukopenia
11/19/2003CN1456261A Slight fever acne capsule preparing method
11/19/2003CN1456212A External applied preparation preparing method for hairing and nourishing hair
11/19/2003CN1456207A Plane warts cream
11/19/2003CN1456200A Medicine for curing acne
11/19/2003CN1456181A Draw out poison liquid for curing sore
11/19/2003CN1456180A Medicine for curing leucoderma and preparing method thereof
11/19/2003CN1456178A External applied medicine for curing burn and preparing method thereof
11/19/2003CN1456170A External applied medicine composition containing vitamin š�*
11/19/2003CN1127970C Ointment for treating burn and its preparing process
11/19/2003CN1127968C Oral medicine for vitiligo and production thereof
11/19/2003CN1127966C 'Hehe' ointment and its preparing process
11/19/2003CN1127964C Chinese medicine for treating dermatopathy (leukoderma and psoriasis)
11/19/2003CN1127961C Exterior-applied medicine for treatnig dermatopathy and its preparing process
11/19/2003CN1127957C Exterior-applied medicine for treating chilblains
11/18/2003US6649648 Administering 1-chroman, 1-thiochroman or quinoline derivative as anticarcinogenic or antimetastasis agent
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
1 ... 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 ... 1065